Browsing by Author Wang, Zhijie

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 70 next >
Issue Date Title Author(s)
2015 Acquired Resistance Mechanisms in Small Cell Lung Cancer Mediated by the Cancer Stem Cell Marker Calcium Channel alpha 2 delta 1 Subunit Wang, Jie;Yu, Jiangyong;Tian, Yanhua;Bai, Hua;Wang, Zhijie;Yu, Sifan
2015 Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations Wang, Zhijie;Shen, Zhirong;Li, Zhenxiang;Duan, Jianchun;Fu, Shuai;Liu, Zhentao;Bai, Hua;Zhang, Zemin;Zhao, Jun;Wang, Xiaodong;Wang, Jie
2015 Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. Wang, Jie;Wang, Zhijie;Li, Zhenxiang;Shen, Zhirong;Fu, Shuai;Liu, Zhentao;Cheng, Liang;Bai, Hua;Duan, Jianchun;Zhao, Jun;Wang, Shuhang;Zhuo, Minglei
2015 Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. Wang, Jie;Wang, Zhijie;Li, Zhenxiang;Shen, Zhirong;Fu, Shuai;Liu, Zhentao;Cheng, Liang;Bai, Hua;Duan, Jianchun;Zhao, Jun;Wang, Shuhang;Zhuo, Minglei
Apr-2020 Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors Wang, Zhijie;Duan, Jianchun;Wang, Guoqiang;Zhao, Jing;Xu, Jiachen;Han, Jiefei;Zhao, Zhengyi;Zhao, Jun;Zhu, Bo;Zhuo, Minglei;Sun, Jianguo;Bai, Hua;Wan, Rui;Wang, Xin;Fei, Kailun;Wang, Shuhang;Zhao, Xiaochen;Zhang, Yuzi;Huang, Mengli;Huang, Depei;Qi, Chuang;Gao, Chan;Bai, Yuezong;Dong, Hua;Xiong, Lei;Tian, Yanhua;Wang, Di;Xu, Chunwei;Wang, Wenxian;Li, Junling;Hu, Xingsheng;Cai, Shangli;Wang, Jie
2013 ANALYSIS OF SENSITIVITY OF LUNG SQUAMOUS CARCINOMA WITH EGFR MUTATION TO EGFR-TKIS AND RESISTANT MECHANISM Wang, Zhijie;Li, Zhenxiang;Yang, Xiaodan;Bai, Hua;Zhuo, Minglei;Duan, Jianchun;Wang, Jie
2018 Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer Lv, Chunxin;Liu, Xiuju;Zheng, Qiwen;Chen, Hanxiao;Yang, Xue;Zhong, Jia;Wang, Yuyan;Duan, Jianchun;Wang, Zhijie;Bai, Hua;Wu, Meina;Zhao, Jun;Wang, Jie;Wang, Ziping;An, Tongtong;Zhuo, Minglei
2009 The application of SnS nanoparticles to bulk heterojunction solar cells Wang, Zhijie;Qu, Shengchun;Zeng, Xiangbo;Liu, Junpeng;Zhang, Changsha;Tan, Furui;Jin, Lan;Wang, Zhanguo
2019 Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel Wang, Zhijie;Duan, Jianchun;Cai, Shangli;Han, Miao;Dong, Hua;Zhao, Jun;Zhu, Bo;Wang, Shuhang;Zhuo, Minglei;Sun, Jianguo;Wang, Qiming;Bai, Hua;Han, Jiefei;Tian, Yanhua;Lu, Jing;Xu, Tongfu;Zhao, Xiaochen;Wang, Guoqiang;Cao, Xinkai;Li, Fugen;Wang, Dalei;Chen, Yuejun;Bai, Yuezong;Zhao, Jing;Zhao, Zhengyi;Zhang, Yuzi;Xiong, Lei;He, Jie;Gao, Shugeng;Wang, Jie
1-Jun-2022 Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via promoting M2 macrophages polarization. Sun, Yiting;Ma, Yuanyuan;Tian, Zhihua;Liu, Xijuan;Yan, Xiang;Zhao, Wei;Wang, Jie;Wang, Zhijie
Feb-2021 Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial Fan, Yun;Zhao, Jun;Wang, Qiming;Huang, Dingzhi;Li, Xingya;Chen, Jianhua;Fang, Yong;Duan, Jianchun;Zhou, Caicun;Hu, Yanping;Yang, Haihua;Hu, Yi;Zhou, Jianying;Lin, Xiaoyan;Wang, Lifeng;Wang, Zhijie;Xu, Yanjun;Zhang, Tao;Shi, Wei;Zou, Jianjun;Wang, Jie
Aug-2020 Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial Wang, Jie;Fan, Yun;Zhao, Jun;Wang, Qiming;Huang, Dingzhi;Li, Xingya;Chen, Jianhua;Fang, Yong;Wang, Zhijie;Zhou, Caicun;Hu, Yanping;Yang, Haihua;Hu, Yi;Zhou, Jianying;Lin, Xiaoyan;Wang, Lifeng;Xu, Yanjun;Li, Hanying
2013 Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations An, Tongtong;Wang, Jie;Bai, Hua;Wang, Zhijie;Zhao, Jun;Duan, Jianchun;Zhuo, Minglei;Wu, Meina;Wang, Yuyan;Wang, Shuhang
2017 Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Wan, Rui;Wang, Zhijie;Lee, J. Jack;Wang, Shuhang;Li, Qingqing;Tang, Fuchou;Wang, Jin;Sun, Yu;Bai, Hua;Wang, Di;Zhao, Jun;Duan, Jianchun;Zhuo, Minglei;An, Tongtong;Wu, Meina;Chen, Zhaoli;Yang, Zhenlin;Wang, Jie
2016 Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience Hou, Ming-Mo;Wang, Zhijie;Janku, Filip;Piha-Paul, Sarina;Naing, Aung;Hong, David;Westin, Shannon;Coleman, Robert L.;Sood, Anil K.;Tsimberidou, Apostolia M.;Subbiah, Vivek;Wheler, Jennifer;Zinner, Ralph;Lu, Karen;Meric-Bernstam, Funda;Fu, Siqing
2013 Cytoplasmic ER beta expression to predict efficacy and survival of EGFR-TKI in EGFR-mutant NSCLC Wang, Zhijie;Wang, Jie;Wang, Xiaodong;Shen, Zhirong;Ding, Xiaosheng;Bai, Hua;Duan, Jianchun;An, Tongtong;Wang, Yuyan;Zhuo, Minglei;Wang, Shuhang;Wu, Meina
2013 CYTOPLASMIC ERBEXPRESSION PREDICTS POORLY EFFICACY AND SURVIVAL OF EGFR-TKI IN EGFR MUTANT NSCLC Wang, Zhijie;Li, Zhenxiang;Bai, Hua;Wang, Jie;Zhao, Jun;Wu, Meina
2013 Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer Bai, Hua;Wang, Zhijie;Wang, Yuyan;Zhuo, Minglei;Zhou, Qinghua;Duan, Jianchun;Yang, Lu;Wu, Meina;An, Tongtong;Zhao, Jun;Wang, Jie
2012 The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI Huang, Zhen;Wang, Zhijie;Bai, Hua;Wu, Meina;An, Tongtong;Zhao, Jun;Yang, Lu;Duan, Jianchun;Zhuo, Minglei;Wang, Yuyan;Wang, Shuhang;Wang, Jie
2018 Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial Wang, Zhijie;Cheng, Ying;An, Tongtong;Gao, Hongjun;Wang, Kai;Zhou, Qing;Hu, Yanping;Song, Yong;Ding, Cuimin;Peng, Feng;Liang, Li;Hu, Yi;Huang, Cheng;Zhou, Caicun;Shi, Yuankai;Zhang, Li;Ye, Xin;Zhang, Meizhuo;Chuai, Shaokun;Zhu, Guanshan;Hu, Jin;Wu, Yi-long;Wang, Jie
Showing results 1 to 20 of 70 next >